Cite
HARVARD Citation
Cloughesy, T. et al. (2020). A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE). Neuro-oncology. 22 (5), pp. 705-717. [Online].